Patent · US Active

Monoclonal antibodies against HER2 epitope and methods of use thereof

US9738720B2 · kind B2 · utility

3Cited by

6References

30Claims

0Family size

Assignee

Mersana Therapeutics, Inc. · US

Inventors

Natalya D. Bodyak · Boston, US
Michael J. DeVit · Sudbury, US
Eric Krauland · Lebanon, US
Timothy B. Lowinger · Carlisle, US
Peter U. Park · Lexington, US
Bianka Prinz · Lebanon, US
Aleksandr V. Yurkovetskiy · Littleton, US

Key dates

Filing date	Nov 4, 2016
Grant date	Aug 22, 2017
Priority date	—
Expiry date	Nov 4, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides fully human monoclonal antibodies that recognize HER2. The invention further provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic, and prophylactic indications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.